Financial, market and economic news

How Do Pfizer’s and Moderna’s COVID Vaccine Results Compare?

We’ve now heard interim results for two of the leading coronavirus vaccine candidates. Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) announced initial data for their experimental COVID-19 vaccine BNT162b2 on Nov. 9, 2020. Moderna (NASDAQ: MRNA) followed up a week later with interim results for its coronavirus vaccine candidate, mRNA-1273. In this Motley Fool Live video recorded on Nov. 16, Healthcare and Cannabis Bureau Chief Corinne Cardina and writer Keith Speights discuss how Pfizer’s and Moderna’s results compare.

Continue reading

Read More

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More

Privacy & Cookies Policy